Genes responding to Canakinumab therapy in SJIA are -inversely - disregulated in adult onset Still's disease

Παρόμοια τεκμήρια

• Gene-expression analysis of adult-onset Still’s disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity
  ανά: Nirmala, Nanguneri, κ.ά.
  Έκδοση: (2015)
• Canakinumab for Treatment of Adult-Onset Still’s Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
  ανά: Kedor, Claudia, κ.ά.
  Έκδοση: (2020)
• Therapy with canakinumab for adult-onset still's disease
  ανά: E. L. Nasonov
  Έκδοση: (2019-04-01)
• Distinct gene expression signatures characterize strong clinical responders vs non-responders to Canakinumab in children with sJIA
  ανά: Verweyen, Emely L, κ.ά.
  Έκδοση: (2021)
• Development and Role in Therapy of Canakinumab in Adult-Onset Still’s Disease
  ανά: Galozzi, Paola, κ.ά.
  Έκδοση: (2018)